Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Recruiting

• Conditions: Extranodal NK/T-cell Lymphoma

• Registration Number: NCT04554511
• Lead Sponsor: Sun Yat-sen University

Brief Summary

This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.

Detailed Description

This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.

Study Timeline

• Study Start: 2020-08-28
• Study First Submitted: 2020-09-12
• Study First Submitted QC: 2020-09-12
• Study First Posted: 2020-09-18
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-15
• Last Update Posted: 2023-06-18
• Primary Completion: 2024-01-01
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients newly diagnosed with ENKTL
• Patients diagnosed between January 1, 2000 and August 31, 2020
• Patients older than 18 years

Exclusion Criteria

• Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival	5 year	Time between the date of diagnosis and any kinds of death

Secondary Outcome Measures

Name	Time	Method
Progression-free survival	5 year	Time between the date of diagnosis and any kinds of death or relapse/progression

Trial Locations

Locations (1)

Sun Yat-sen University Cancer Center; 🇨🇳 Guangzhou, Guangdong, China